A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

NCT07136545 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Taipei Veterans General Hospital, Taiwan

Collaborators